Radiant Innovation - Asset Resilience Ratio
Radiant Innovation (3373) has an Asset Resilience Ratio of 1.04% as of December 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Check Radiant Innovation PP&E and investment ratio to assess the company's strategic physical and investment asset allocation.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2017–2025)
This chart shows how Radiant Innovation's Asset Resilience Ratio has changed over time. See 3373 net asset quality score to measure how much of total assets are equity-financed.
Liquid Assets Composition Over Time
This chart breaks down Radiant Innovation's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see Radiant Innovation stock valuation.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | NT$0.00 | 0% |
| Short-term Investments | NT$8.94 Million | 1.04% |
| Total Liquid Assets | NT$8.94 Million | 1.04% |
Asset Resilience Insights
- Limited Liquidity: Radiant Innovation maintains only 1.04% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
Radiant Innovation Industry Peers by Asset Resilience Ratio
Compare Radiant Innovation's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Cochlear Ltd
AU:COH |
Medical Devices | 9.76% |
|
Shenzhen New Industries Biomedical
SHE:300832 |
Medical Devices | 9.95% |
|
Jafron Biomedical Co Ltd
SHE:300529 |
Medical Devices | 39.15% |
|
HOB Biotech Group Corp Ltd
SHG:688656 |
Medical Devices | 2.62% |
|
Polynovo Ltd
AU:PNV |
Medical Devices | 0.04% |
|
Shanghai ZJ Bio-Tech Co. Ltd. A
SHG:688317 |
Medical Devices | 10.88% |
|
Dirui Industrial Co Ltd
SHE:300396 |
Medical Devices | 6.89% |
|
Emvision Medical Devices Ltd
AU:EMV |
Medical Devices | 0.06% |
Annual Asset Resilience Ratio for Radiant Innovation (2017–2025)
The table below shows the annual Asset Resilience Ratio data for Radiant Innovation.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-12-31 | 1.04% | NT$8.94 Million ≈ $281.75K |
NT$861.31 Million ≈ $27.14 Million |
-0.13pp |
| 2024-12-31 | 1.17% | NT$10.95 Million ≈ $344.86K |
NT$935.42 Million ≈ $29.47 Million |
-0.16pp |
| 2023-12-31 | 1.33% | NT$13.01 Million ≈ $409.76K |
NT$979.30 Million ≈ $30.85 Million |
+0.14pp |
| 2022-12-31 | 1.18% | NT$13.23 Million ≈ $416.75K |
NT$1.12 Billion ≈ $35.18 Million |
+0.13pp |
| 2021-12-31 | 1.05% | NT$13.03 Million ≈ $410.36K |
NT$1.24 Billion ≈ $39.07 Million |
+0.14pp |
| 2020-12-31 | 0.91% | NT$17.46 Million ≈ $550.05K |
NT$1.92 Billion ≈ $60.64 Million |
-3.15pp |
| 2017-12-31 | 4.06% | NT$32.66 Million ≈ $1.03 Million |
NT$804.84 Million ≈ $25.36 Million |
-- |
About Radiant Innovation
Radiant Innovation Inc. engages in the design and development of infrared technology products in Taiwan, Japan, and Germany. It offers medical infrared thermometers, including infrared ear, non-contact forehead, and multi-function thermometers, as well as probe cover; and CO2 monitors. The company also offers industrial infrared thermometers, infrared precision thermal imagers, infrared precision… Read more